Stage IV Colon Cancer Vanishes After a Rheumatoid-Arthritis Drug Is Stopped
A 79-year-old woman with biopsy-confirmed Stage IVA transverse colon cancer and synchronous liver metastasis showed complete disappearance of viable tumor at both sites after her rheumatoid-arthritis drug tocilizumab (an anti-IL-6 receptor antibody) was discontinued; surgery found only fibrosis and scar tissue. Reported in Surgical Case Reports (2026).
A 79-year-old woman with biopsy-confirmed Stage IVA transverse colon cancer and synchronous liver metastasis showed complete disappearance of viable tumor at both sites after her rheumatoid-arthritis drug tocilizumab (an anti-IL-6 receptor antibody) was discontinued; surgery found only fibrosis and scar tissue. Reported in Surgical Case Reports (2026).
A fuller write-up of the documentation and analysis is in progress.
Sources
Tagged by proximity to the event. Primary sources are direct or contemporaneous; tertiary are downstream retellings.
- 1.Primaryacademic
Full text of the case report. Source for patient age/sex, Stage IVA (cT2N1aM1a) diagnosis, pre-treatment biopsy confirmation of both sites, tocilizumab 480 mg for rheumatoid arthritis, surgical procedures, no-viable-tumor pathology, and the authors' IL-6-withdrawal immune-rebound hypothesis.
- 2.Primaryacademic
Official journal landing page reached via DOI 10.70352/scrj.cr.25-0710. Confirms exact title, full author list, journal, and Vol 12, Issue 1 (2026).